SCHEMBL24288140

SCHEMBL24288140

Cc1ncc(-c2ccc(F)cc2F)c(C)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 2/20 0.38
▸ ROS1 P08922 1/20 0.38
▸ ADRA2A P08913 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ ALOX5AP P20292 2/20 0.37
▸ FEN1 P39748 2/20 0.37
▸ DPP4 P27487 2/20 0.37
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ PIK3C3 Q8NEB9 1/20 0.35
▸ MAPK14 Q16539 2/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27095191 0.83 KMO (0.36) KMOALOX5APFEN1DPP4
SCHEMBL24288096 0.81 RPS6KA3 (0.44) KMOHDAC1HDAC2ALOX5APFEN1
SCHEMBL27625630 0.80 NSD2 (0.39) ADRA2AADRA2CHDAC1ALOX5APFEN1
SCHEMBL24288255 0.77 USP2 (0.42) ALOX5APFEN1DPP4MAPK14
SCHEMBL24288152 0.77 RPS6KA3 (0.47) ALOX5APFEN1MAPK14
SCHEMBL17813814 0.74 POLQ (0.40) KMOHDAC1HDAC2DPP4GABRG2
SCHEMBL30160394 0.73 GRM2 (0.36) ROS1DPP4MAPK14DHODH
SCHEMBL24009652 0.73 GRM2 (0.36) ROS1DPP4MAPK14DHODH
SCHEMBL9135463 0.72 ALDH1A1 (0.52) KMO
SCHEMBL4754291 0.71 JAK3 (0.44) KMOGABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053823-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR Cerevance, Inc. (US) 2022-03-17 — — WO disclosed
Send feedback